Epidemiology of Klebsiella Pneumoniae in China

Zhejiang University

Status: Unknown

Conditions: Klebsiella Pneumoniae Infection

Treatments: Other: no intervention

Study type: Observational

Funder types: Other

Identifiers

NCT03598543

SRRSH-China-KP

Details and patient eligibility

About

Klebsiella pneumoniae is one of the most common pathogens causing both community-onset and nosocomial infection. More worse, the emergency of Carbapenem-Resistant Klebsiella pneumoniae (CRKP) had cause the clinical therapy be very difficult. However, there is not much empirical data as to the prevalence, risk factors, characteristics,outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.Thus, the study was aimed to investigate the epidemiology and risk factors, characteristics, outcomes and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Full description

All the patients with culture positive of Klebsiella pneumoniae were screened and reported to the the clinical doctors and confirmed by them. And the clinical characteristics of the patiens, such as baseline data, outcomes etc, were recorded. Finially, to find the prevalence, risk factors, characteristics, outcome and the rationality of the current therapy for the Klebsiella pneumoniae infection in China.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• new confirmed community-onset or noscomial infection of Klebsiella pneumoniae infection

Exclusion criteria

• Age<18, or >85 years old; Mixed infection of Klebsiella pneumoniae and other microbes

Trial design

100 participants in 2 patient groups

Carbapenem-Sensitive K. pneumoniae

Description:

Any patients with clinical confirmed Carbapenem-Sensitive Klebsiella pneumoniae infection.

Treatment:

Other: no intervention

Carbapenem-Resistant K. pneumoniae

Description:

Patients with clinical confirmed Carbapenem-Resistant Klebsiella pneumoniae infection.

Treatment:

Other: no intervention